ICON plc (ICLR)
173.48
+1.25
(+0.73%)
USD |
NASDAQ |
Aug 24, 16:00
173.51
+0.03
(+0.02%)
After-Hours: 20:00
ICON Enterprise Value : 15.98B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 15.98B |
| August 21, 2026 | 15.89B |
| August 20, 2026 | 16.04B |
| August 19, 2026 | 15.91B |
| August 18, 2026 | 15.49B |
| August 17, 2026 | 15.67B |
| August 14, 2026 | 15.19B |
| August 13, 2026 | 15.52B |
| August 12, 2026 | 15.50B |
| August 11, 2026 | 15.37B |
| August 10, 2026 | 15.41B |
| August 07, 2026 | 15.29B |
| August 06, 2026 | 15.03B |
| August 05, 2026 | 15.21B |
| August 04, 2026 | 14.70B |
| August 03, 2026 | 14.82B |
| July 31, 2026 | 15.22B |
| July 30, 2026 | 15.37B |
| July 29, 2026 | 16.34B |
| July 28, 2026 | 16.50B |
| July 27, 2026 | 15.62B |
| July 24, 2026 | 15.39B |
| July 23, 2026 | 15.74B |
| July 22, 2026 | 15.50B |
| July 21, 2026 | 15.45B |
| Date | Value |
|---|---|
| July 20, 2026 | 15.42B |
| July 17, 2026 | 15.71B |
| July 16, 2026 | 15.71B |
| July 15, 2026 | 15.87B |
| July 14, 2026 | 15.56B |
| July 13, 2026 | 15.41B |
| July 10, 2026 | 15.54B |
| July 09, 2026 | 15.62B |
| July 08, 2026 | 15.36B |
| July 07, 2026 | 15.61B |
| July 06, 2026 | 15.79B |
| July 02, 2026 | 15.95B |
| July 01, 2026 | 16.10B |
| June 30, 2026 | 16.00B |
| June 29, 2026 | 16.03B |
| June 26, 2026 | 15.79B |
| June 25, 2026 | 15.11B |
| June 24, 2026 | 14.89B |
| June 23, 2026 | 13.71B |
| June 22, 2026 | 13.56B |
| June 18, 2026 | 13.96B |
| June 17, 2026 | 13.75B |
| June 16, 2026 | 13.77B |
| June 15, 2026 | 14.09B |
| June 12, 2026 | 13.98B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 57.13B |
| Medpace Holdings, Inc. | 16.90B |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | 68.87M |
| Avantor, Inc. | 13.04B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 72.58M |
| Revenue (Quarterly) | 2.063B |
| Total Expenses (Quarterly) | 1.991B |
| EPS Diluted (Quarterly) | 0.9381 |
| Gross Profit Margin (Quarterly) | 18.83% |
| Profit Margin (Quarterly) | 3.52% |
| Earnings Yield | 0.32% |
| Operating Earnings Yield | 6.27% |
| Normalized Earnings Yield | 2.987 |